MCID: PRP007
MIFTS: 50

Priapism malady

Categories: Genetic diseases, Rare diseases, Reproductive diseases, Cardiovascular diseases

Aliases & Classifications for Priapism

About this section

Aliases & Descriptions for Priapism:

Name: Priapism 10 45 47 12 36 65
Priapism, Familial Idiopathic 45 65
 
Familial Idiopathic Priapism 45
Mentulagra 10

Classifications:



External Ids:

Disease Ontology10 DOID:9286
ICD1027 N48.30, N48.3
ICD9CM29 607.3
MeSH36 D011317
NCIt42 C85022
UMLS65 C0033117, C1867771

Summaries for Priapism

About this section
Wikipedia:68 Priapism is a potentially painful medical condition in which the erect penis does not return to its... more...

MalaCards based summary: Priapism, also known as priapism, familial idiopathic, is related to low-flow priapism and pulmonary blastoma, and has symptoms including (priapism) or (erection - painful), sexual function symptom/complaint male and painful ejaculation. An important gene associated with Priapism is PDE5A (Phosphodiesterase 5A), and among its related pathways are NO-dependent CFTR activation (normal and CF) and Nitric oxide stimulates guanylate cyclase. Affiliated tissues include thyroid, heart and prostate, and related mouse phenotypes are reproductive system and renal/urinary system.

Disease Ontology:10 A peripheral vascular disease characterized by blood trapped in the penis that is unable to drain.

Related Diseases for Priapism

About this section

Diseases related to Priapism via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 92)
idRelated DiseaseScoreTop Affiliating Genes
1low-flow priapism12.2
2pulmonary blastoma10.4NOS3, PDE5A
3sickle cell disease10.4
4stuttering10.4
5acute sphenoidal sinusitis10.4NOS3, PDE5A
6paraphilia disorder10.3NOS3, PDE5A
7acrodermatitis10.3F5, NOS3
8preeclampsia/eclampsia 110.2F5, NOS3
9sickle cell anemia10.2
10leukemia10.2
11coagulation protein disease10.1F13A1, F5
12blood platelet disease10.1F13A1, F5
13chronic cholangitis10.1AQP1, F5
14prostatitis10.1
15ocular hypertension10.1F5, NOS3
16oral squamous cell carcinoma10.1F5, NOS3, PDE5A
17islet cell tumor10.1F5, NOS3, PDE5A
18bernard-soulier syndrome, type a210.1F5, NOS3, PDE5A
19myeloid leukemia10.0
20dysgnathia complex10.0F13A1, F5
21adenocarcinoma10.0
22schizophrenia10.0
23spinal cord injury10.0
24persistent genital arousal disorder10.0
25campylobacteriosis9.9F13A1, F5
26prostate cancer9.9
27thalassemia9.9
28purpura9.9
29pregnancy loss, recurrent 29.9F13A1, F5
30prostate adenocarcinoma9.9
31protein c deficiency9.9
32atrial heart septal defect9.8NOS3, PDE5A
33postpartum depression9.8F13A1, F5
34fabry disease9.8
35lymphoma9.8
36impotence9.8
37protein s deficiency9.8
38paraphimosis9.8
39cocaine abuse9.8
40peritonitis9.8
41systemic lupus erythematosus9.6
42esophageal cancer9.6
43renal cell carcinoma9.6
44chordoma9.6
45multiple myeloma9.6
46hypertriglyceridemia9.6
47pick disease9.6
48peyronie's disease9.6
49pulmonary hypertension9.6
50chronic lymphocytic leukemia9.6

Graphical network of the top 20 diseases related to Priapism:



Diseases related to priapism

Symptoms for Priapism

About this section

UMLS symptoms related to Priapism:


(priapism) or (erection - painful), sexual function symptom/complaint male, painful ejaculation, painful penile erection

Drugs & Therapeutics for Priapism

About this section

Drugs for Priapism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
PrazosinapprovedPhase 35119216-56-94893
Synonyms:
1-(3-Amino-6,7-dimethoxy-2- quinazolinyl)-4-(2-furanyl-carbonyl)piperazine hydrochloride
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine
19216-56-9
2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline
2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone
5-25-13-00365 (Beilstein Handbook Reference)
AB00053528
AC1L1J6T
AKOS000310009
BCBcMAP01_000227
BPBio1_001006
BRD-K49111258-001-02-8
BRD-K49111258-003-05-7
BRN 0768345
BSPBio_000914
BSPBio_001036
BSPBio_002221
Bio1_000365
Bio1_000854
Bio1_001343
Bio2_000358
Bio2_000838
C07368
C19H21N5O4
CAS-19237-84-4
CHEBI:8364
CHEMBL2
CID4893
CP-12299
D08411
DB00457
DivK1c_000375
EINECS 242-885-8
Furazosin
HMS1362D17
HMS1792D17
HMS1990D17
HMS2089G09
HSDB 3298
IDI1_000375
IDI1_002113
Justac
KBio1_000375
KBio2_000376
KBio2_001302
KBio2_002944
KBio2_003870
KBio2_005512
KBio2_006438
KBio3_000731
KBio3_000732
KBio3_001721
KBioGR_000376
KBioGR_000965
KBioSS_000376
KBioSS_001302
 
L000666
LS-140002
Lentopres
Minipress
Minipress (TN)
Minipress Xl
MolPort-000-891-036
NCGC00016740-01
NCGC00016740-02
NCGC00016740-03
NCGC00016740-14
NCGC00024324-02
NCGC00024324-04
NCGC00024324-05
NCGC00024324-06
NCGC00024324-07
NCGC00024324-08
NCGC00024324-09
NCI60_002417
NINDS_000375
Oprea1_314778
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)- (9CI)
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)- (8CI)
Prazocin
Prazosin (INN)
Prazosin HCl
Prazosin Hydrochloride
Prazosin [INN:BAN]
Prazosina
Prazosina [INN-Spanish]
Prazosine
Prazosine [INN-French]
Prazosinum
Prazosinum [INN-Latin]
Prestwick0_000947
Prestwick1_000947
Prestwick2_000947
Prestwick3_000947
SMP1_000063
SPBio_001297
SPBio_003073
ST075549
STK301545
Spectrum2_001289
Spectrum3_000551
Spectrum4_000483
Spectrum5_001365
Spectrum_000822
TL8001573
TNP00312
Tocris-0623
UNII-XM03YJ541D
Vasoflex
ZINC00601304
[3H]-Prazosin
[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone
prazosin
2Adrenergic AgentsPhase 34204
3Neurotransmitter AgentsPhase 314795
4Antihypertensive AgentsPhase 33618
5Adrenergic alpha-1 Receptor AntagonistsPhase 3405
6Adrenergic alpha-AntagonistsPhase 3586
7Adrenergic AntagonistsPhase 31253
8
HydroxyureaapprovedPhase 2188127-07-13657
Synonyms:
1-HYDROXYUREA
127-07-1
4-03-00-00170 (Beilstein Handbook Reference)
55291_FLUKA
AC1L1GF8
AC1Q4ZXK
AI3-51139
BB_SC-7256
BRN 1741548
BSPBio_002164
Bio1_000451
Bio1_000940
Bio1_001429
Biosupressin
C07044
CCRIS 958
CHEBI:44423
CHEMBL467
CID3657
Carbamohydroxamic Acid
Carbamohydroxamic acid
Carbamohydroximic Acid
Carbamohydroximic acid
Carbamohydroxyamic Acid
Carbamohydroxyamic acid
Carbamoyl Oxime
Carbamoyl oxime
Carbamyl Hydroxamate
Carbamyl hydroxamate
Carrbamoyl Oxime
D00341
D006918
DB01005
DRG-0253
DivK1c_000556
Droxia
Droxia (TM)
Droxia (TN)
E0723DBA-5AF3-49D1-B5F6-59420AB87AC9
EINECS 204-821-7
EU-0100596
FT-0083575
H 8627
H0310
H20210
H8627_SIGMA
HMS1920F09
HMS2091L17
HMS501L18
HSDB 6887
HU
HYDREA (TN)
HYDROXY-UREA
Hidrix
Hidroxicarbamida
Hidroxicarbamida [INN-Spanish]
Hydrea
Hydrea (TM)
Hydrea, Biosupressin, Cytodrox, Hydroxyurea
Hydreia
Hydroxicarbamidum
Hydroxycarbamid
Hydroxycarbamide
Hydroxycarbamide (JAN/INN)
Hydroxycarbamidum
Hydroxycarbamidum [INN-Latin]
Hydroxycarbamine
Hydroxyharnstoff
Hydroxyharnstoff [German]
Hydroxylurea
Hydroxyurea
Hydroxyurea (D4)
Hydroxyurea (USP)
Hydroxyurea [USAN:BAN]
Hydroxyurea(d4)
 
Hydura
Hydurea
I05-0250
IDI1_000556
Idrossicarbamide
Idrossicarbamide [DCIT]
Idrossicarbamide [Dcit]
KBio1_000556
KBio2_001389
KBio2_003957
KBio2_006525
KBio3_001384
KBioGR_000383
KBioSS_001389
LS-709
Litaler
Litalir
Lopac-H-8627
Lopac0_000596
MLS001332381
MLS001332382
MLS002153389
MolMap_000029
MolPort-000-003-971
Mylocel
N-(Aminocarbonyl) Hydroxyamine
N-Carbamoylhydroxylamine
N-HYDROXY UREA
N-Hydroxymocovina
N-Hydroxymocovina [Czech]
N-Hydroxyurea
NCGC00015520-01
NCGC00015520-02
NCGC00015520-07
NCGC00093974-01
NCGC00093974-02
NCGC00093974-03
NCGC00093974-04
NCGC00093974-05
NCI C04831
NCI-C04831
NCI60_002773
NCIMech_000139
NHY
NINDS_000556
NSC 32065
NSC32065
Onco-Carbide
Onco-carbide
Oncocarbide
Oxyurea
S-phase/G-1 interface inhibitor
S1896_Selleck
SK 22591
SMR000059149
SPBio_000247
SPECTRUM1500344
SQ 1089
SQ-1089
Siklos
Spectrum2_000064
Spectrum3_000462
Spectrum4_000012
Spectrum5_000836
Spectrum_000909
Sterile Urea
TL8000673
UNII-X6Q56QN5QC
Ureaphil
WLN: ZVMQ
carbamide oxide
hydroxyaminomethanamide
hydroxyurea
nchembio.573-comp3
nchembio.90-comp4
nchembio749-comp3
tetratogen: inhibits ribonucleoside diphosphate reductase
9
Tadalafilapproved, investigationalPhase 2140171596-29-5110635
Synonyms:
(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
171596-29-5
1xoz
6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
AC1L380B
ADCIRCA
Acdirca
Adcirca
C429886
CHEBI:41488
CHEMBL779
CID110635
CPD000466321
Cialis
Cialis (TN)
Cialis, GF 196960, IC 351, ICOS 351, Tadalafil
D02008
DB00820
FT-0080116
GF 196960
GF-196960
 
HMS2051N17
HSDB 7303
IC 351
IC-351
ICOS 351
Ic351
KS-1117
LS-186558
LS-187015
LS-187770
Lilly brand of tadalafil
MLS000759426
MLS001165782
MLS001195644
MLS001424132
MolPort-002-885-864
S1512_Selleck
SAM001246586
SMR000466321
Tadalafil
Tadalafil (JAN/USAN/INN)
Tadalafil [USAN]
Tadanafil
UNII-742SXX0ICT
ZINC03993855
10Nucleic Acid Synthesis InhibitorsPhase 23836
11AntibodiesPhase 24477
12ImmunoglobulinsPhase 24477
13Antibodies, MonoclonalPhase 22413
14Sildenafil CitratePhase 2304171599-83-0
15Vasodilator AgentsPhase 22926
16Phosphodiesterase InhibitorsPhase 21062
17Phosphodiesterase 5 InhibitorsPhase 2513
18Contraceptives, OralPhase 23734
19CitrateNutraceuticalPhase 21001
20
Citric AcidnutraceuticalPhase 2100177-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
21
Methyltestosteroneapproved47458-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
17beta-Hydroxy-17-methylandrost-4-en-3-one
 
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methitest
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Testred C-III
Virilon
22
Silodosinapproved22160970-54-75312125
Synonyms:
KAD 3213
 
KMD 3213
Rapaflo
Urief
23
Tamsulosinapproved, investigational151106133-20-4129211
Synonyms:
(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
106133-20-4
5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide
5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide
5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide
5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide
5-{(2R)-2-[(2-{[2-(ethyloxy)phenyl]oxy}ethyl)amino]propyl}-2-(methyloxy)benzenesulfonamide
AC1L2V76
BIDD:GT0261
C07124
C20H28N2O5S
CHEBI:9398
CHEMBL836
CID129211
D08560
DB00706
FT-0082894
Flomax
Flomax (TN)
Flowmax
 
HMS2090P15
Harnal
LS-31578
MolPort-003-850-388
NCGC00167442-01
STK626950
TAMSULOSIN
Tamsolusin
Tamsulon
Tamsulon (TN)
Tamsulosin
Tamsulosin (INN)
Tamsulosin Hydrochloride
Tamsulosin [INN:BAN]
Tamsulosina
Tamsulosina [INN-Spanish]
Tamsulosine
Tamsulosine [INN-French]
Tamsulosinum
Tamsulosinum [INN-Latin]
UNII-G3P28OML5I
YM-617
24
Testosteroneapproved, investigational47458-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
Aveed
Axiron
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depo-testosterone
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Fortesta
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
Intrinsa
 
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Natesto nasal gel
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Gel
Testosterone Heptanoate
Testosterone Hydrate
Testosterone Propionate
Testosterone Undecanoate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
Vogelxo
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
25
Testosterone enanthate474315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
26Testosterone 17 beta-cypionate474
27Testosterone undecanoate474
28Hormones11748
29Anabolic Agents375
30Androgens1162
31Antineoplastic Agents, Hormonal4256
32Hormone Antagonists10002
33Hormones, Hormone Substitutes, and Hormone Antagonists9988

Interventional clinical trials:

idNameStatusNCT IDPhase
1AScVS and/ or Prazosin for Scorpion EnvenomationCompletedNCT00753064Phase 3
2Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain CrisesCompletedNCT01895361Phase 2
3Sildenafil for Treatment of Priapism in Men With Sickle Cell AnemiaTerminatedNCT00940901Phase 2
4Tadalafil for Treatment of Priapism in Men With Sickle Cell AnemiaTerminatedNCT00538564Phase 2
5Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and PrevalenceCompletedNCT00300235
6Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal EventsRecruitingNCT02539771
7Androgen Regulation of Priapism in Sickle Cell DiseaseNot yet recruitingNCT01940718
8Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave LithotripsyNot yet recruitingNCT01560091

Search NIH Clinical Center for Priapism


Cochrane evidence based reviews: priapism

Genetic Tests for Priapism

About this section

Anatomical Context for Priapism

About this section

MalaCards organs/tissues related to Priapism:

33
Thyroid, Heart, Prostate, Myeloid, Brain, Kidney, Liver

Animal Models for Priapism or affiliated genes

About this section

MGI Mouse Phenotypes related to Priapism:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053898.4AQP1, F13A1, KL, NOS3, TGFBR3
2MP:00053678.2AQP1, ITGAV, KL, NOS3, SLC4A1
3MP:00053698.0ITGAV, KL, NOS3, SLC4A1, TGFBR3
4MP:00053767.0AQP1, F13A1, F5, ITGAV, KL, NOS3
5MP:00053976.8AQP1, F13A1, ITGAV, KL, NOS3, SLC4A1
6MP:00107686.4AQP1, F13A1, F5, ITGAV, KL, NOS3
7MP:00053856.1AQP1, F13A1, F5, ITGAV, KL, NOS3

Publications for Priapism

About this section

Articles related to Priapism:

(show top 50)    (show all 593)
idTitleAuthorsYear
1
The possible protective effects of dipyridamole on ischemic reperfusion injury of priapism. (27136481)
2016
2
Management of priapism in adult men. (25785343)
2015
3
Acute scrotal pain and priapism: an early sign of progression in metastatic renal cell carcinoma? (25694639)
2015
4
How I treat priapism. (25810489)
2015
5
Molecular Pathophysiology of Priapism: Emerging Targets. (25392014)
2014
6
Malignant priapism secondary to isolated penile metastasis from a renal pelvic carcinoma. (25210564)
2014
7
A Case of Painless Pediatric Priapism and Cough. (25285386)
2014
8
Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism. (24076963)
2014
9
Priapism Induced by Boceprevir-CYP3A4 Inhibition and I+-Adrenergic Blockade: Case Report. (24092799)
2014
10
18F-FDG PET/CT in a case of malignant priapism secondary to metastasis from mucoid adenocarcinoma of the cecum. (23334147)
2013
11
Unsatisfactory outcomes of prolonged ischemic priapism without early surgical shunts: our clinical experience and a review of the literature. (22922321)
2013
12
Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress. (23844149)
2013
13
Priapism in children: a comprehensive review and clinical guideline. (24135215)
2013
14
Castration for treating recurrent priapism: can we do better? (21799141)
2012
15
Priapism: comorbid factors and treatment outcomes in a contemporary series. (22811705)
2012
16
High-flow priapism due to a malignant glomus tumor (glomangiosarcoma) of the corpus cavernosum. (19912496)
2011
17
Treating stuttering priapism. (21914108)
2011
18
Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature. (21654814)
2011
19
Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation. (21127306)
2011
20
A crackling priapism related to Fournier's gangrene in a patient on chronic peritoneal dialysis. (20600298)
2010
21
Favorable response to intrathecal, but not oral, baclofen of priapism in a patient with spinal cord injury. (19179913)
2009
22
Posttraumatic high-flow priapism: case report, current management options and literature review. (19623873)
2009
23
Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism. (18466270)
2008
24
Posttraumatic nonischemic priapism treated with autologous blood clot embolization. (18173765)
2008
25
Sickle cell trait and priapism: a case report and review of the literature. (19116025)
2008
26
Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case. (18823322)
2008
27
Superselective arterial embolization for patients with high-flow priapism: results of follow-up for five or more years. (17453510)
2007
28
Association between priapism and concurrent use of risperidone and Ginkgo biloba. (17908535)
2007
29
Priapism in the oncology setting. (17441393)
2007
30
The Winter procedure as management for prolonged low-flow priapism: a case report. (18055300)
2007
31
Stuttering priapism after ingestion of alfuzosin. (17070382)
2006
32
High-flow priapism as a complication of a veno-occlusive priapism: two case reports. (16224494)
2006
33
Priapism: new concepts in the pathophysiology and new treatment strategies. (17052448)
2006
34
Is the combination of superselective transcatheter autologous clot embolization and duplex sonography-guided compression therapy useful treatment option for the patients with high-flow priapism? (16079900)
2006
35
Distal cavernosum-glans shunts for ischemic priapism. (16839333)
2006
36
Irreversible priapism during olanzapine and lithium therapy. (15144518)
2004
37
Priapism following ingestion of tamsulosin. (12771780)
2003
38
Priapism secondary to hypertriglyceridemia. (12576856)
2003
39
Evidence-based radiology problems. High-flow post-traumatic priapism: transcatheter embolotherapy: October 2003-September 2004. (14593770)
2003
40
The incidence and management of priapism in Western Australia: a 16 year audit. (12934055)
2003
41
Priapism associated with two atypical antipsychotic agents. (12173794)
2002
42
Management strategy for arterial priapism: therapeutic dilemmas. (12394712)
2002
43
Interventional treatment of traumatic priapism. (12431145)
2002
44
The management of low-flow priapism with the immediate insertion of a penile prosthesis. (12460352)
2002
45
Unusual complications of warfarin therapy: skin necrosis and priapism. (10931425)
2000
46
Re: Chronic myeloid leukaemia presenting as priapism in children: need for multidisciplinary approach. (12862132)
2000
47
Priapism in a patient with protein C deficiency. (9352148)
1997
48
Permanent open shunt as a reason for impotence or reduced potency after surgical treatment of priapism in 26 patients. (8750051)
1995
49
Priapism associated with chronic cocaine abuse. (8042894)
1994
50
Priapism associated with intranasal cocaine abuse. (2304177)
1990

Variations for Priapism

About this section

Expression for genes affiliated with Priapism

About this section
Search GEO for disease gene expression data for Priapism.

Pathways for genes affiliated with Priapism

About this section

GO Terms for genes affiliated with Priapism

About this section

Biological processes related to Priapism according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of angiogenesisGO:00457669.6AQP1, NOS3
2blood coagulationGO:00075968.8F13A1, F5, NOS3

Molecular functions related to Priapism according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1fibroblast growth factor bindingGO:00171349.6KL, TGFBR3

Sources for Priapism

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet